| Financial Year |
March 31 2023 |
| Monetary Funds |
2,069,154,023.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
52,786,127.46 |
| Accounts Receivable |
439,016,875.65 |
| Advances to Suppliers |
22,386,291.55 |
| Other Receivables |
4,314,690.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
705,212,448.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,312,106,492.41 |
| Total Current Assets |
4,674,642,163.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
420,128,649.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,592,643.49 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
102,930,569.47 |
| Deferred Income Tax Assets |
61,048,334.38 |
| Other Non-Current Assets |
62,587,702.94 |
| Sub-Total of Non-Current Assets |
757,038,920.29 |
| Total Assets |
5,431,681,083.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,459,093.04 |
| Accounts Payable |
427,218,548.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
90,211,055.58 |
| Taxes Payable |
45,758,384.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
572,204,673.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,493,737.42 |
| Other Current Liabilities |
9,205,941.21 |
| Sub-Total of Current Liabilities |
1,243,341,593.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
73,193,877.24 |
| Deferred Income Tax Liabilities |
8,818,939.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
117,760,875.98 |
| Total Liabilities |
1,361,102,469.75 |
| Paid-In Capital(Or Share Stock) |
400,000,000.00 |
| Capital Surplus |
1,336,926,065.54 |
| Surplus Reserve |
200,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,133,553,740.20 |
| Minority Stockholder's Interest |
98,808.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,070,479,805.74 |
| Owner's Equity（Stockholder's Equity） |
4,070,578,613.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,431,681,083.51 |
